High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
about
Emerging roles for HMGB1 protein in immunity, inflammation, and cancerThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityHMGB1 in health and disease.Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosisHematopoietic stem and multipotent progenitor cells produce IL-17, IL-21 and other cytokines in response to TLR signals associated with late apoptotic products and augment memory Th17 and Tc17 cells in the bone marrow of normal and lupus miceImpact of Tobacco Smoking and Type-2 Diabetes Mellitus on Public Health: A Cerebrovascular Perspective.Blockade of Extracellular High-Mobility Group Box 1 Attenuates Systemic Inflammation and Coagulation Abnormalities in Rats with Acute Traumatic Coagulopathy.Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development.Blocking HMGB1 signal pathway protects early radiation-induced lung injury.Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.Gene Therapy for Autoimmune Disease.Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release.HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
P2860
Q27015835-76D813E1-91C4-40C3-9F9B-A22207381D0AQ28384138-4B7699CC-99A0-4772-AD59-B6085580820BQ34622835-9AEFA335-506A-426A-8302-93DDDF503EC1Q35177161-AD24FC5E-03C6-4113-9FFA-8ADB6FEDCD01Q36421539-6A8C77EE-0A16-4D2A-A862-A4A9CC7D058CQ36455589-83BC8749-91E6-4D2F-9D8A-F8FDCAE53828Q37135898-E3C209B5-03B8-4FF1-A745-69D2F927EF67Q37335446-A3A8A389-9D71-421C-B2BE-F92776986E7AQ38794037-E813709D-7E62-4B04-9168-4C0F3D1BD7A6Q41643283-92AC8FE6-8B30-45DC-9F63-4CFB995208B0Q42197380-021C8DC1-DF84-42BD-9F5D-FDA1EC651B49Q47241431-7A5EC26D-58A9-483A-9533-71D20275836EQ52151935-E05D141C-8C93-4993-AB39-3FA2B27A17DAQ53014578-8B6EB3D8-9B4C-4962-BCA7-AB6628508223Q53677430-325A96A0-D3F1-431C-84F9-605A3AD5CA43Q55714316-339BDFD1-56A2-4539-AF45-60F2F83CCBBFQ57113385-74DE2958-5EB8-4429-BB15-D9DF8A950B56
P2860
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High-mobility group box 1 prot ...... autoimmune encephalomyelitis.
@en
type
label
High-mobility group box 1 prot ...... autoimmune encephalomyelitis.
@en
prefLabel
High-mobility group box 1 prot ...... autoimmune encephalomyelitis.
@en
P2093
P2860
P1476
High-mobility group box 1 prot ...... autoimmune encephalomyelitis.
@en
P2093
Andrew P Robinson
Christopher T Harp
Gwendolyn E Goings
Matthew W Caldis
Stephen D Miller
P2860
P356
10.1016/J.JAUT.2013.02.005
P577
2013-03-17T00:00:00Z